Adherence to Aromatase Inhibitors: The Role of Partners

Abramson Cancer Center at Penn Medicine40 enrolled

Overview

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Breast Cancer Survivors

Interventions

SurveyOTHER

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women and partners of women with stage I-III breast cancer who 1. have completed primary cancer treatments (surgery, chemotherapy, radiotherapy) 2. have experienced AI side effects 3. live with a romantic partner. Exclusion Criteria:

Locations (1)

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Number of Surveys Completed

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.